Skip to main content
Veterinary Medicines

HIPRAGUMBORO-CH80, Lyofilizovaná vakcína k okulonazální a perorální aplikaci

Authorised
  • Infectious bursal disease virus, strain CH/80, Live

Product identification

Medicine name:
HIPRAGUMBORO-CH80, Lyofilizovaná vakcína k okulonazální a perorální aplikaci
Active substance:
  • Infectious bursal disease virus, strain CH/80, Live
Target species:
  • Chicken
Route of administration:
  • In drinking water use
  • Oculonasal use

Product details

Active substance and strength:
  • Infectious bursal disease virus, strain CH/80, Live
    6.50
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for suspension
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken
      • Meat and offal
        0
        day
      • Egg
        0
        day
  • Oculonasal use
    • Chicken
      • Meat and offal
        0
        day
      • Egg
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD09
Authorisation status:
  • Valid
Authorised in:
  • Czechia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 97/061/02-C
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."